AR and prostate carcinoma: As shown in Fig 4A, EBR decreased the CALR and CALNX expression profiles time-dependently by causing caspase-dependent apoptotic cell death in both AR-expressing and AR-non-expressing prostate cancer cells (Fig 4A and 4B).